A new study conducted by researchers at the Seattle-based University of Washington School of Medicine, published in the recent issue of Cell Press’ journal Immunity, titled “Autoimmunity Initiates in Nonhematopoietic Cells and Progresses via Lymphocytes in an Interferon-Dependent Autoimmune Disease” has provided vital insights into the development of autoimmune diseases.
A team of researchers at the Temple University headed by professor Chang-Hee Won have developed a tactile imaging sensor, a prototype device capable of quantifying and emulating human tactile sensations.
CriticareSystems, a manufacturer of patient monitoring systems and accessories, headquartered in Waukesha, WI, has announced that it has won a contract to provide nGenuityVital Signs Monitors to several major hospitals located in Tyumen Oblast, the third largest province in Russia.
Endosense, a medical technology company focused on improving safety, accessibility and efficacy associated with catheter ablation for treating cardiac arrhythmias has launched the TactiCath 75 force-sensing ablation catheter in Europe and has released the results of the EFFICAS I clinical trial to demonstrate the effect of contact force in catheter ablation procedures.
PositiveID, a developer of medical devices and diagnostic systems for diabetes management, bio-threat detection and rapid testing, has announced that the clinical trial of Easy Check, a non-invasive device for the detection of breath glucose, will be launched for diabetic patients in a few weeks.
A group of students from Missouri University of Science and Technology and the International Genetically Engineered Machine Foundation (iGEM) chapter have developed a biological sensor system, which has utilized DNA segments embedded in bacteria, in order to sense glucose. Diabetic patients may get a new kind of test strip from this recent development.
Reportlinker.com has included a new report titled ‘Glucose Monitoring Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017’ to its list of offering.
The Interreg project Medisen is developing novel biosensors that have the capacity to detect lung cancer in a person’s exhaled breath. Tecnalia, the University of Perpignan and the Instituto de Tecnologías Químicas Emergentes de La Rioja (Inter-Química) are participating in this project.
EarlySense, a provider of proactive patient care technologies, has declared that the company’s non-contact patient monitoring device can be significantly used as a risk assessment tool for preventing the occurrence of pressure ulcers, using the results of post regulatory approval clinical and interventional studies, which was released in the Journal of Patient Safety issued in December 2011.
Scientists from the Bernstein Center for Computational Neuroscience Tübingen, the University of Bielefeld, the Max Planck Institute for Biological Cybernetics and the University of Oxford have made a research that is to be released in the Current Biology journal.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.